demonstrated that either anti‐PD‐L1 or anti‐CD73 antibodies alone failed to inhibit tumor growth in a xenograft mouse model of EGFR‐mutated NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.